Presentation Information
[LS05-1]One year and eight months since the clinical implementation of anti-Aβ antibody drugs ―Now the role of MRI is being reconsidered―
○Aya Tokumaru (Department of Diagnostic Radiology, Tokyo Metropolitan Institute for Geriatrics and Gerontology)
Comment
To browse or post comments, you must log in.Log in